Related by context. All words. (Click for frequent words.) 67 receptor tyrosine kinase inhibitor 66 selective modulator 66 alpha 2A 64 5 HT2A receptor 63 reversible inhibitor 63 inverse agonist 63 mTOR inhibitors 62 multi kinase inhibitor 62 adenosine A2A 62 thiazolides 62 gamma secretase inhibitors 62 partial agonist 62 immune modulating 61 kinase inhibition 61 YONDELIS R 61 receptor inhibitor 61 CCR2 61 Degarelix 61 Luteinizing Hormone Releasing Hormone 61 tyrosine kinase inhibitor 61 Akt inhibitor 61 sodium glucose cotransporter 61 humanised monoclonal antibody 61 proteasome inhibitor 60 receptor antagonists 60 SGLT 2 60 reversible inhibitors 60 Aplidin 60 immunopathology 60 Talabostat 60 5 HT4 60 HSP# inhibitor 60 novel peptide 60 nicotinic acetylcholine receptor 60 proteasome inhibitors 60 nucleoside analogues 60 5 HT4 receptor 60 erythropoietic 60 PEGylated Fab fragment 60 flavopiridol 60 IAP inhibitor 60 Dapagliflozin 60 Blinatumomab 60 Interferon alpha 60 forodesine 60 highly selective inhibitor 60 PDE4 inhibitor 59 irreversible inhibitor 59 immunomodulatory therapy 59 alpha 2A adrenoceptor 59 2A receptor agonist 59 ADP receptor antagonist 59 oral prodrug 59 multitargeted 59 Tyrima 59 factor TNF 59 antisense inhibitors 59 MEK inhibitors 59 cilengitide 59 chimeric monoclonal antibody 59 pyrimidines 59 orally dosed 59 pDCs 59 insulin sensitizers 59 nucleoside analog 59 EGFR inhibitors 59 receptor modulators 59 thyroid hormone receptor 59 antiarrhythmic 59 JAK inhibitor 59 Valdoxan 59 pharmacokinetic interactions 59 angiogenesis inhibitor 59 gamma secretase inhibitor 58 estrogen receptor beta 58 5 Fluorouracil 58 alkylating agent 58 blood clot dissolving 58 neuroactive 58 #HT#A 58 factor Xa 58 fosbretabulin 58 Dasatinib 58 polymerase inhibitor 58 BMS # 58 orally administered inhibitor 58 antimitotic 58 Sudhir Agrawal D.Phil 58 anti fibrotic 58 visilizumab 58 immune modulator 58 CCR5 antagonist 58 thetreatment 58 Pathway Inhibitor 58 oral ghrelin agonist 58 platelet inhibitor 58 Factor VIIa 58 erlotinib Tarceva 58 glucagon receptor 58 Neuropeptide Y 58 nucleoside analogue 58 Cytoxan 58 Deforolimus 58 osteoblast 58 pathophysiological effects 58 Squalamine 58 kinase inhibitor 58 somatostatin analogue 58 chemopreventive agent 58 IAP inhibitors 58 TNF Tumor Necrosis Factor 58 Cancidas 58 antiproliferative effects 58 vivo validation 58 serotonin reuptake inhibitor 57 interleukin IL -# 57 immunomodulator 57 immuno modulatory 57 Lixivaptan 57 Gleevec resistant 57 insulin sensitizing 57 potent antiproliferative 57 5 HT6 receptor 57 PEGylated anti 57 Ziprasidone 57 colorectal carcinoma 57 receptor agonist 57 inhibits protein synthesis 57 5 HT1A receptor 57 tubulin binding 57 histone deacetylase inhibitors 57 selective inhibition 57 PPARγ 57 endothelin receptor 57 mTOR mammalian target 57 Granulocyte Colony Stimulating Factor 57 Tumor necrosis factor 57 PI3K inhibitor 57 vinca alkaloid 57 cellular cytotoxicity 57 5 HT3 receptor 57 NS3 protease 57 selective antagonist 57 receptor modulator 57 chemokine receptor 57 mGluR4 57 mGluR2 NAM 57 HGS# 57 receptor inhibitors 57 selectively inhibits 57 Irinotecan 57 TRV# [001] 57 prokinetic 57 DFMO 57 cytoprotective 57 glucocorticoid receptors 57 SGS# 57 thienopyridines 57 Elvitegravir 57 peripherally restricted 57 anti angiogenic agents 57 inhaled formulation 57 receptor CXCR4 57 anti secretory 57 Syk 57 recurrent glioblastoma multiforme 57 herpetic keratitis 57 IMiDs R 57 dopamine D2 57 biased ligand 57 cardioprotective effects 57 alefacept 57 receptor blocker 57 clomipramine 57 neuroregenerative 57 DACH platinum 56 intravesical instillation 56 targeting PCSK9 56 EGF receptor 56 norepinephrine reuptake inhibitor 56 antifolates 56 PNP inhibitor 56 somatostatin analog 56 cathepsins 56 Valproic acid 56 JAK2 inhibitor 56 enkephalin 56 p# inhibitor 56 histone deacetylase inhibitor 56 cyclooxygenase 2 56 CB2 receptor 56 meropenem 56 gemcitabine Gemzar 56 imatinib Gleevec ® 56 p# inhibitors 56 peroxisome proliferator activated 56 orally bioavailable 56 Romidepsin 56 5 HT1A 56 peripherally acting 56 PSN# [002] 56 2A agonist 56 Cyclosporin 56 demethylating agents 56 Factor Xa inhibitor 56 demonstrated antitumor activity 56 tumor suppressive 56 strong CYP#A# inducer 56 receptor partial agonist 56 factor Xa inhibitor 56 AEG# 56 type glutamate receptor 56 Mipomersen 56 intratumoral injection 56 brain penetrant 56 insulin sensitizer 56 investigational humanized monoclonal antibody 56 prostanoid 56 CDK inhibitor 56 selective estrogen receptor 56 ACEON R 56 receptor activator 56 Anti VEGF 56 Panzem R NCD 56 vascular disrupting agents 56 histone deacetylase HDAC inhibitors 56 signal transduction inhibitor 56 antisense inhibitor 56 antiplatelet agent 56 endothelin receptor antagonists 56 enzyme inhibitor 56 potent inhibitors 56 reuptake inhibitors 56 imatinib Gleevec 56 Inhaled nitric oxide 56 muscarinic 56 HDACi 56 pharmacological chaperone 56 phosphate S1P 56 Nedd4 56 resolvins 56 lenalidomide dexamethasone 56 Preclinical studies suggest 56 Surgical resection 56 acadesine 56 Parathyroid hormone 56 fulvestrant 56 methyl D aspartate 56 androgen receptor AR 56 dual orexin receptor 56 demethylating agent 56 HepDirect prodrug 56 dexpramipexole 56 cytostatic 55 ropinirole Requip 55 Factor VEGF 55 gonadotropin releasing hormone GnRH 55 AT1R 55 somatostatin 55 selectively inhibiting 55 nilotinib Tasigna ® 55 Selective Inhibitor 55 PD LID 55 Gefitinib 55 thrombopoietin 55 chemotherapeutic agent 55 receptor antagonist 55 adrenoceptor 55 angiotensin II receptor 55 radiation sensitizer 55 CYP #A# 55 glucocorticoid receptor 55 lenalidomide Revlimid R 55 Cethrin R 55 endogenous ligand 55 ZOLINZA 55 M1 muscarinic 55 antifibrotic 55 class mGluR5 inhibitor 55 leukotriene receptor antagonists 55 immunosuppressive regimen 55 5HT 55 selective agonist 55 antifolate 55 CG# [003] 55 mineralocorticoid 55 adenosine receptor 55 IGF 1R 55 kidney urologic 55 Th2 cytokines 55 mTOR inhibitor 55 receptors PPARs 55 inhibit platelet function 55 amylin 55 TNF inhibitor 55 LPA1 receptor 55 neurokinin 1 55 PKC inhibitors 55 phosphatases 55 RezularTM 55 TNFalpha 55 prolyl hydroxylase inhibitors 55 EGFR tyrosine kinase inhibitor 55 cyclin dependent kinase inhibitor 55 Topoisomerase II 55 serotonin norepinephrine reuptake inhibitors 55 C5aR 55 Pharmacokinetic studies 55 radiolabeled TM# 55 cortisol receptor 55 alpha#beta# integrin 55 SGLT2 inhibitors 55 NS4A 55 cyclic peptide 55 histone deacetylase 55 Angiotensin converting enzyme 55 TNFα 55 cholecystokinin CCK 55 D aspartate NMDA receptor 55 Dr. Cassian Yee 55 astemizole 55 sphingosine 1 55 chimeric antibody 55 cannabinoid receptor 55 IDO inhibitor 55 Imatinib mesylate 55 antiinflammatory 55 immunomodulatory effects 55 founding Image Comics 55 soluble tumor necrosis 55 angiotensin receptor blocker ARB 55 c myc gene 55 5alpha reductase 55 ARG# 55 neuroprotectant 55 liposomal formulation 54 muscarinic antagonist 54 receptor PPAR 54 hepatotoxic 54 mecamylamine 54 anti leukemic 54 ERK1 2 54 heparins 54 E3 ligase 54 RANK ligand 54 pegylated liposomal doxorubicin 54 immunoregulatory 54 antiangiogenic 54 adrenoceptor agonist 54 immunomodulatory 54 NS5B polymerase 54 therapeutic monoclonal antibody 54 ATL# [002] 54 TNF α 54 vitro pharmacology 54 phosphodiesterase inhibitors 54 RNA antagonists 54 vascular disrupting agent 54 targeted radiotherapeutic 54 subtype selective 54 clavulanate 54 antituberculosis 54 Lovastatin 54 nonsteroidal 54 humanized anti 54 ALB # 54 kinesin spindle protein KSP 54 5 HT2A 54 c MYC 54 GSK3B 54 Janus kinase 54 immunosuppressant 54 Modrenal 54 peptide CGRP 54 superficial bladder cancer 54 receptor agonists 54 muscarinic receptors 54 thrombin receptor 54 SGLT2 54 compound AEZS 54 Akt activation 54 Azacitidine 54 immunomodulation 54 2 methoxyestradiol 54 uPAR 54 CGRP 54 Bicalutamide 54 tricyclic 54 dopamine D1 54 immunotherapeutic vaccine 54 BAY #-# 54 Bevasiranib 54 Adenoscan R 54 5 lipoxygenase 54 lung fibrosis 54 Erimos 54 potentiator 54 Vincristine 54 antisense oligonucleotide 54 NMDA receptor antagonist 54 oral JAK1 54 factor G CSF 54 mimetics 54 N methyl 54 Wnt signaling pathway 54 subcutaneous formulation 54 PTP 1B 54 trial evaluating PRX# 54 EP3 receptor 54 CINQUIL 54 PI3K/mTOR 54 small molecule inhibitor 54 calcitonin gene related 54 beta adrenergic 54 sulindac 54 antibody MT# 54 PHX# 54 hypoxia inducible factor 54 PPAR agonist 54 intramuscular interferon beta 1a 54 potentiation 54 Almorexant 54 BAL# [001] 54 selective inhibitors 53 IL 1ß 53 kallikrein 53 orally administered synthetic retinoid 53 A2A receptor 53 cell lymphoma CTCL 53 T#I [002] 53 vanilloid receptor 53 investigational oral 53 neuropsychiatric diseases 53 neurotrophic 53 VAPRISOL 53 selective estrogen receptor modulators 53 reversing heparin 53 immunosuppressant drug 53 mGluR5 inhibition 53 vesicular monoamine transporter 53 SUTENT ® 53 PEGylated interferon 53 dose dependently 53 NKG2D 53 glycoprotein GP IIb IIIa 53 selective antagonists 53 HuLuc# 53 highly selective endothelin 53 synthetic retinoid 53 amyloid cascade 53 EP #R 53 NK1 53 masitinib 53 immunotoxin 53 selective inhibitor 53 eotaxin 53 Receptor Antagonist 53 AKT1 53 Teplizumab 53 anticancer agent 53 hyperalgesia 53 paroxetine Paxil 53 ErbB2 53 mGluR2 positive 53 humanized monoclonal antibody 53 Dr. Joseph Giacino 53 direct thrombin inhibitors 53 RANK Ligand 53 aspirin clopidogrel 53 NMDA antagonist 53 2DG 53 selective serotonin 2C receptor 53 serotonin receptor 53 Spironolactone 53 antiepileptics 53 factor TNF receptor 53 colon carcinoma 53 Teriflunomide 53 beta arrestin 53 agonism 53 antitumoral 53 Archexin 53 maximally tolerated lipid lowering 53 SSc 53 investigational therapies 53 PKC inhibitor 53 immunomodulating 53 CB1 antagonists 53 norepinephrine reuptake inhibitor SNRI 53 H2 receptor antagonist 53 rufinamide 53 5 HT2B receptor 53 prodrugs 53 Locked Nucleic Acid LNA 53 antidiabetic 53 alpha2 53 c MET 53 Bruton tyrosine kinase Btk 53 Rebecca Leeb 53 lipoglycopeptide 53 MAPK pathway 53 thymidylate synthase 53 xenograft models 53 gabapentin Neurontin 53 adrenergic receptor agonist 53 bleomycin 53 IGF IR 53 receptor blockers 53 antiangiogenic agent 53 oncogenic signaling 53 HGS ETR2 53 dermatologic diseases 53 cytokine IL 53 agonists antagonists 53 bazedoxifene selective estrogen receptor 53 antidepressive 53 VEGF receptor 53 histone deacetylases 53 opioid receptor antagonist 53 RNA silencing 53 Hedgehog inhibitor 53 nicotinic 53 Pralatrexate 53 CRTH2 53 phosphatidylinositol 3 53 monoamine oxidase inhibitors 53 Gleevec inhibits 53 CD# antibody [001] 53 Zoraxel TM 53 small molecule Hedgehog 53 biologic therapy 53 secreted protein 53 mitogen activated protein 53 cognitive enhancer 53 parecoxib 53 Raf kinase 53 prognostic biomarker 53 R Saizen R 53 idarubicin 53 torezolid 53 neuroleptic 53 * olmesartan medoxomil 53 FAAH 52 pro apoptotic 52 tranilast 52 aberrantly activated 52 potent inhibitor 52 G CSFs 52 small molecule inhibitors 52 Endothelin 52 cell mediated cytotoxicity 52 cyclooxygenase 52 molecule epidermal 52 oral anticancer 52 subcutaneously administered 52 analgesic effects 52 investigational oral antiplatelet 52 Voreloxin 52 VMAT2 52 P#X# receptor 52 Sphingomab 52 opioid antagonist 52 injectable formulation 52 IL 1β 52 transient receptor 52 Tissue Factor 52 systemically administered 52 mRNA antagonist 52 arginine vasopressin AVP 52 neuronal differentiation 52 anti angiogenic drugs 52 casein kinase 52 PPARg 52 GRK5 52 topiramate Topamax 52 Spiegelmer ® 52 partial agonists 52 Dr. Sosne 52 parthenolide 52 mitogenic 52 Liprotamase 52 Bortezomib 52 TGF beta1 52 long acting muscarinic 52 AMPA kainate 52 GAD# 52 inhibitory effect 52 p# mitogen activated 52 γ secretase 52 recombinant enzyme 52 levocetirizine 52 VEGFb 52 preclinical efficacy 52 tubulin inhibitors 52 Hormonal therapy 52 progesterone receptor 52 cotransporter 52 STAT3 52 druggable target 52 author Randall Irmis 52 dihydropyridine 52 anti thrombotic 52 drug zotarolimus 52 Known generically 52 Iloperidone 52 HCV replication 52 anti androgen 52 gonadotrophin releasing hormone 52 siRNA therapeutics 52 selective agonists 52 TG# [003] 52 Androgen receptor 52 Angiotensin 52 investigational atypical antipsychotic 52 prostaglandin D2 52 PPAR gamma agonists 52 vardenafil Levitra 52 receptor subtype 52 intravenously administered 52 angiotensin receptor 52 Enkephalin 52 gastrin 52 Mestinon 52 IFN alpha 52 prostaglandin E1 52 Lpathomab 52 gonadotrophin releasing hormone GnRH 52 Fenretinide 52 antitumor effect 52 ß blockers 52 exocrine pancreas 52 HCV protease 52 selective estrogen receptor modulator 52 bowel syndrome 52 Avanafil 52 prognostic marker 52 iron chelators 52 Adenoscan 52 Kantarjian 52 imatinib resistance 52 protein mTOR 52 agonist 52 propranolol Inderal 52 anxiolytic 52 Tetrabenazine 51 cholesterol homeostasis 51 Cymbalta duloxetine 51 Fas ligand 51 chemokine 51 apoptosis induced 51 glutamate receptors 51 Androgen Receptor 51 epigenetic therapies 51 cytotoxin 51 Laquinimod 51 angiotensin II receptor blocker 51 mineralocorticoid receptor 51 ospemifene 51 HDAC inhibitor 51 RAV# 51 downstream effectors 51 oral proteasome inhibitor 51 #ME# 51 Hsp# chaperone system 51 isoform 51 FGFR 51 bispecific antibody 51 mitogen activated protein kinase 51 thromboxane A2 51 cardiometabolic disorders 51 overactivation 51 Glucagon Like Peptide 51 TNF á 51 peptide hormone 51 development DSC# novel 51 Ambrisentan 51 vasoconstrictor 51 endothelin receptor antagonist DARA 51 Alpha lipoic acid 51 macrolide antibiotics 51 agent VDA 51 Prozac fluoxetine 51 commercialized STEALTH TM 51 H2 antagonists 51 Hypoxia Inducible Factor 51 Hsp# chaperone 51 William Sandborn MD 51 ranpirnase 51 tumor vascular disrupting 51 Vaprisol 51 N acetylcysteine 51 oncoprotein 51 enzymatic pathways 51 triterpenoids 51 Dr. Karsenty 51 MUC1 51 Receptor Antagonists 51 constipation OIC 51 biobetter 51 Homspera TM 51 metabonomics 51 glutamyl 51 PU H# 51 antifibrinolytic 51 CORT # 51 sodium glucose transporter 51 Aldosterone 51 Chronic Myeloid Leukemia CML 51 quinoline 51 owner Greg Trulson 51 factor alpha TNF 51 Rasenick 51 anticoagulant reversing agent 51 pramipexole Mirapex 51 treating neuropathic pain 51 5 HT2C receptor 51 synthetic analogues 51 imatinib resistant 51 developing TB4 51 EOquin TM phase 51 Estriol 51 urothelial cancer 51 ghrelin agonist 51 lysophosphatidic acid LPA 51 bone metabolism 51 evaluating picoplatin 51 ligand TRAIL 51 Saizen R 51 serotonin reuptake 51 oral dihydropyrimidine dehydrogenase DPD 51 orally inhaled 51 LY# [002] 51 NK 1R 51 Bupropion 51 potently inhibits 51 chemotherapeutic drugs 51 Bystolic nebivolol 51 Mellaril 51 GPR# agonists 51 antagonist LAMA 51 pathway inhibitor 51 Trofex 51 BN# [002] 51 small molecule agonists 51 receptor monoclonal antibody 51 vivo pharmacology 51 embryonal carcinoma 50 neuronal nicotinic receptors NNRs 50 diagnostic molecular imaging 50 CD# monoclonal antibody 50 CYP#A# inhibitors 50 #HT# 50 retinoid 50 Angiotensin II 50 ischemia reperfusion injury 50 Myeloid 50 noscapine 50 potential vanilloid 50 Adenosine 50 pharmacologically active isomer 50 SIRT2 50 EnteroMedics proprietary neuroblocking technology 50 Oasmia 50 naturally occurring enzyme 50 DHFR 50 cytotoxic agents 50 Tumour Necrosis Factor 50 pegylated recombinant 50 immune stimulatory 50 urokinase plasminogen activator 50 anti angiogenic 50 clioquinol 50 PDE7 inhibitors 50 phosphoinositide 50 BZL# 50 Helicobacter pylori eradication 50 vasodilators 50 transmembrane protein 50 anti inflammatory cytokines 50 sapropterin dihydrochloride 50 vivo preclinical 50 R bisoprolol Euthyrox 50 Small Molecule 50 gamma agonists 50 inhibitor 50 selective androgen receptor modulators 50 CA4P 50 siRNA therapeutic 50 cyclase 50 Zamvil 50 topical calcineurin inhibitors 50 Angiox R 50 endoplasmic reticulum stress 50 regenerative biology 50 Youdim 50 EP1 receptor 50 neuroimmunology 50 prognostic indicator 50 inhibit COX 50 AT1 receptor 50 endogenous cannabinoid 50 Posiphen TM 50 insulin sensitizing drug 50 PSN# [001] 50 bile acid sequestrants 50 mTOR signaling 50 Perifosine 50 pharmacodynamics 50 Po yo 50 RISPERDAL ® 50 chronic myocardial ischemia 50 Phase III multicenter 50 peptidomimetic 50 homolog 50 antiarrhythmic drug 50 statins cholesterol lowering 50 5 HT6 50 Balaglitazone 50 Spiegelmer 50 protein misfolding diseases 50 excitatory neurotransmitter 50 hematopoiesis 50 antitumour 50 injectable investigational 50 MAXY G# 50 neuroprotective properties 50 osteoprotegerin OPG 50 incretin 50 AMPAKINE 50 Angiocept 50 Sphingosine 1 50 kinesin spindle protein 50 metformin sulfonylurea 50 Citicoline 50 author Marcia Stefanick 50 neural regeneration 50 selective A1 adenosine 50 opiate antagonist 50 small molecule VR1 50 TNF alpha antagonist 50 ACV1 50 adrenoreceptor 49 NMES 49 dopamine reuptake 49 PPAR alpha 49 NK1R 49 metformin sulfonylureas 49 neuropathy sparing 49 opioid induced bowel dysfunction 49 muscle contractility 49 thrombin inhibiting aptamer 49 secretagogue 49 anticholinergic agents 49 urography 49 evaluating MGCD# [002] 49 pharmacologic approaches 49 rhIGFBP 3 49 Y2 receptor 49 infinitely self indulgent 49 Eric Nestler 49 bortezomib 49 neuroprotection 49 neurokinin 49 SomatoKine 49 combretastatin A4 phosphate CA4P 49 ribonuclease 49 positive allosteric modulator 49 neuropilin 49 prostacyclin 49 sphingosine kinase 49 HIF 1alpha 49 angiotensin II receptor antagonist 49 inhibit metastasis 49 microRNA miR 49 estrogen receptor antagonist 49 neuro protective 49 ENaC 49 2A receptor 49 pharmacologically 49 Kinan Beck 49 anti cholinesterase 49 NR2B 49 Aclidinium 49 CCR5 co 49 reductase inhibitor 49 androgen hormone 49 inhibits tumor 49 Pharmacological 49 Galectin 49 Î ² 49 CB2 receptor selective 49 chemosensitizer 49 Leukotriene 49 GSK 3ß 49 integrin receptor 49 inhibit tumor angiogenesis 49 beta adrenergic receptors 49 opioid antagonists 49 immunotoxins 49 induces apoptosis 49 DURIN TM 49 adipose derived stem cells 49 LPA1 49 potent topoisomerase II 49 HDL Selective Delipidation 49 Rheos System 49 serotonin reuptake inhibitors 49 selective adenosine 49 GABA receptor 49 nicotinic receptor 49 glycoprotein IIb IIIa 49 vasodilator 49 defendant Ahmed Ferhani 49 vitro cytotoxicity 49 oral talactoferrin 49 factor kappa B 49 pharmacotherapies 49 Apo2L 49 Orexin 49 defendant Dale Hausner 49 opioid peptides 49 histamine receptor 49 viral pathogenesis 49 specific protein tyrosine 49 proinflammatory cytokine 49 NeoLipid TM 49 pharmacologic therapy 49 dopaminergic 49 Metabolic Disease 49 Surgical excision 49 noninvasive outpatient 49 cytokine signaling 49 nitric oxide donating 49 oncolytic vaccine 49 adrenergic receptors 49 renin angiotensin aldosterone 49 dopamine receptor 49 Induced pluripotent stem cells 49 acid GABA 49 Small Modular SMIP 49 xanthine oxidase inhibitor 49 agonists 49 injectable urethral bulking 49 AMPAKINE compounds 49 investigational oral inhibitor 49 CTLA 4 49 autologous cellular immunotherapies 49 Milatuzumab 49 axial cables 49 Preclinical studies indicate 49 GABAA receptor 49 antimetastatic 49 anti anginal 49 antiplatelets 49 nanopharmaceutical 49 leukotriene 49 rhITF 49 lipid lowering 49 alpha agonist 49 plasminogen activator 49 mTOR 48 Gewirth 48 induce apoptosis 48 oral isotype selective HDAC 48 ZYBRESTAT fosbretabulin 48 induced phosphorylation 48 developed preclinically 48 ovarian suppression 48 BGC# 48 Neurontin gabapentin 48 Dr. Kantarjian 48 alpha7 NNR 48 amrubicin 48 oral anti arrhythmic 48 PTP1B 48 naturally occurring tannins 48 PKC alpha 48 P. Murali Doraiswamy 48 UNC Lineberger 48 prostaglandin E 48 Celator 48 VE cadherin 48 Atypical antipsychotics 48 Macroplastique ® 48 inverse agonists 48 glutamate receptor 48 genetics immunology 48 Einstein Montefiore 48 MEK1 48 pharmacokinetics pharmacodynamics 48 AFRS TM 48 NR2B selective 48 selectively modulating 48 neuroinflammatory diseases 48 bioactive lipid 48 Migranal 48 inhibition 48 ophthalmology dermatology cardiovascular disease 48 serotonin norepinephrine